134 related articles for article (PubMed ID: 1746705)
1. [Significance of tumor-associated CA-125 antigen in the diagnosis and monitoring of ovarian cancer].
Ial'chenko NA; Levik NN; Musin II
Akush Ginekol (Mosk); 1991 Sep; (9):61-2. PubMed ID: 1746705
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of the tumour markers CA 125 II and CA 72-4 in ovarian carcinoma.
Hasholzner U; Baumgartner L; Stieber P; Meier W; Reiter W; Pahl H; Fateh-Moghadam A
Int J Cancer; 1996 Aug; 69(4):329-34. PubMed ID: 8797878
[TBL] [Abstract][Full Text] [Related]
3. Immunoassay of CA125 in ovarian cancer: a comparison of three assays for use in diagnosis and monitoring.
Fisken J; Leonard RC; Roulston JE
Dis Markers; 1989; 7(1):61-7. PubMed ID: 2653700
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
[TBL] [Abstract][Full Text] [Related]
5. [The value of CA 125 determination in the serum of patients with ovarian cancer].
Bartel U; Johannsen B; Elling D
Zentralbl Gynakol; 1989; 111(5):301-9. PubMed ID: 2728673
[TBL] [Abstract][Full Text] [Related]
6. CA-125 monitoring in the management of ovarian cancer.
Bruzzone M; Onetto M; Campora E; Chiara S; Oliva C; Guido T; Merlini L; Parodi S; Bentivoglio G; Ventrella W
Anticancer Res; 1990; 10(5A):1353-9. PubMed ID: 2241112
[TBL] [Abstract][Full Text] [Related]
7. [Application of monoclonal antibody OC 125 in gynecological oncology].
Wu AR; Wang EY; Wang XX; Jia XH; Li L
Zhonghua Zhong Liu Za Zhi; 1988 Mar; 10(2):132-6. PubMed ID: 3208653
[TBL] [Abstract][Full Text] [Related]
8. [Results of CA-125 tumor marker determination in patients with ovarian carcinoma].
Miladinović D; Paunović R; Paunković N
Jugosl Ginekol Perinatol; 1989; 29(3-4):83-5. PubMed ID: 2601371
[TBL] [Abstract][Full Text] [Related]
9. [Serum level of the tumor marker CA 125 in ovarian pathology].
Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
[TBL] [Abstract][Full Text] [Related]
10. [Prospects of the use of neoplasm antigens as markers of gynecologic diseases].
Adamian LV; Fanchenko ND; Andreeva EN; Novikov EA; Alekseeva ML
Sov Med; 1990; (6):26-9. PubMed ID: 2204116
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
12. Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.
Yuan CC; Ng HT; Tsai LC; Jeng FS; Yeh SH; Tsai YC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):190-7. PubMed ID: 3480793
[TBL] [Abstract][Full Text] [Related]
13. CA 125 as a tumour marker in epithelial ovarian cancer.
Sheehan JD; Duffy MJ; Allen MA; Fennelly JJ
Ir J Med Sci; 1989 Jan; 158(1):10-3. PubMed ID: 2737852
[TBL] [Abstract][Full Text] [Related]
14. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
Duk JM; Aalders JG; Fleuren GJ; Krans M; De Bruijn HW
Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
[TBL] [Abstract][Full Text] [Related]
15. Impact of tumour marker measurements upon management of patients with carcinoma of the ovary.
Rustin GJ
Dis Markers; 1991; 9(3-4):153-8. PubMed ID: 1813207
[TBL] [Abstract][Full Text] [Related]
16. Measurement of CA 125 by an automated microparticle enzyme immunoassay; comparison with a manual enzyme immunoassay.
Mogensen O; Mogensen B
Scand J Clin Lab Invest; 1992 Oct; 52(6):507-12. PubMed ID: 1411262
[TBL] [Abstract][Full Text] [Related]
17. Cyst fluid CA 125 levels in ovarian epithelial neoplasms.
Menczer J; Ben-Baruch G; Moran O; Lipitz S
Obstet Gynecol; 1993 Jan; 81(1):25-8. PubMed ID: 8416456
[TBL] [Abstract][Full Text] [Related]
18. [New prospects in the combined use of tumor markers in epithelial neoplasms of the ovary].
Indraccolo SR; Cecchi A; Thodos A; Brandi S; Carta G
Ann Ostet Ginecol Med Perinat; 1991; 112(1):36-40. PubMed ID: 1929097
[TBL] [Abstract][Full Text] [Related]
19. CA 125 as a marker in epithelial ovarian cancer: Alone and in comparison with CEA.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH; Balar DB; Patel TB
Indian J Cancer; 1987 Dec; 24(4):222-31. PubMed ID: 3505511
[No Abstract] [Full Text] [Related]
20. [Significance of CA 125 antigen levels in patients with ovarian cancer].
Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]